Key terms
About FLGT
Fulgent Genetics, Inc. is a technology company, which engages in the provision of gene testing and sequencing solutions. It offers genes and panels, known mutation, hereditary cancer, carrier screening, and tumor profiling solutions. The company was founded by Ming Hsieh on May 13, 2016 and is headquartered in El Monte, CA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest FLGT news
Mar 06
7:36am ET
Piper Sandler Sticks to Its Hold Rating for Fulgent Genetics (FLGT)
Mar 06
7:23am ET
Fulgent Genetics price target lowered to $25 from $28 at Piper Sandler
Feb 28
7:22am ET
Fulgent Genetics Shares Business Insights in Investor Update
Feb 28
7:19am ET
Fulgent Genetics sees FY24 EPS ($1.05), consensus (95c)
Feb 28
7:17am ET
Fulgent Genetics reports Q4 EPS $28c, consensus (29c)
No recent press releases are available for FLGT
FLGT Financials
Key terms
Ad Feedback
FLGT Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
FLGT Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range